A New Paradigm for Clinical Trials
Paradigm Health is excited to welcome DFJ Growth as our newest investor. Known for backing such category-defining companies as OpenAI, SpaceX, and Coinbase, we are honored to be their first investment in clinical trials after many years of evaluating the industry. This is more than just an infusion of capital; it is a vote of confidence in the progress we have made to re-engineer the clinical trials ecosystem to enhance trial efficiency and reduce the barriers to participation for healthcare providers and their patients.
